Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 1,667.65
-10.95 (-0.65%)
At close: Jan 20, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 277.2 billion as of January 23, 2026. Its market cap has decreased by -11.50% in one year.
Market Cap
277.20B
Enterprise Value
248.21B
Revenue
58.01B
Ranking
n/a
PE Ratio
35.07
Stock Price
1,667.65
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 277.20B, a decrease of -6.70%. That is a compound annual growth rate of -1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 283.92B | 0.08% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 588.57B |
| GlaxoSmithKline Pharmaceuticals | 403.16B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |
| Granules India | 138.61B |
| Caplin Point Laboratories | 132.36B |
| Rubicon Research | 108.64B |